- Home
- ULBI vs RAPT Comparison
ULBI vs RAPT Comparison
Compare ULBI & RAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ULBI
- RAPT
- Stock Information
- Founded
- ULBI 1990
- RAPT 2015
- Country
- ULBI United States
- RAPT United States
- Employees
- ULBI N/A
- RAPT N/A
- Industry
- ULBI Industrial Machinery/Components
- RAPT Biotechnology: Pharmaceutical Preparations
- Sector
- ULBI Miscellaneous
- RAPT Health Care
- Exchange
- ULBI Nasdaq
- RAPT Nasdaq
- Market Cap
- ULBI 135.2M
- RAPT 122.9M
- IPO Year
- ULBI 1992
- RAPT 2019
- Fundamental
- Price
- ULBI $8.93
- RAPT $8.04
- Analyst Decision
- ULBI Strong Buy
- RAPT Buy
- Analyst Count
- ULBI 1
- RAPT 5
- Target Price
- ULBI $14.00
- RAPT $42.00
- AVG Volume (30 Days)
- ULBI 197.4K
- RAPT 109.8K
- Earning Date
- ULBI 07-24-2025
- RAPT 08-07-2025
- Dividend Yield
- ULBI N/A
- RAPT N/A
- EPS Growth
- ULBI N/A
- RAPT N/A
- EPS
- ULBI 0.31
- RAPT N/A
- Revenue
- ULBI $173,275,000.00
- RAPT N/A
- Revenue This Year
- ULBI $31.30
- RAPT N/A
- Revenue Next Year
- ULBI $6.24
- RAPT N/A
- P/E Ratio
- ULBI $28.49
- RAPT N/A
- Revenue Growth
- ULBI 2.74
- RAPT N/A
- 52 Week Low
- ULBI $4.07
- RAPT $5.67
- 52 Week High
- ULBI $12.40
- RAPT $30.60
- Technical
- Relative Strength Index (RSI)
- ULBI 64.06
- RAPT 62.95
- Support Level
- ULBI $7.85
- RAPT $7.04
- Resistance Level
- ULBI $8.46
- RAPT $8.91
- Average True Range (ATR)
- ULBI 0.44
- RAPT 0.84
- MACD
- ULBI -0.08
- RAPT 0.08
- Stochastic Oscillator
- ULBI 60.33
- RAPT 92.53
About ULBI Ultralife Corporation
Ultralife Corp provides products and services ranging from power solutions to communications and electronics systems to customers across the globe in the government and defense, medical, safety and security, energy, and industrial sectors. The company designs, manufactures, installs, and maintains power and communications systems including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems and accessories, and custom-engineered systems. The company's segments include Battery and Energy Products, and Communications Systems. It generates maximum revenue from the Battery and Energy Products segment, and from the U.S. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, and various other non-rechargeable batteries.
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.